Article
Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas.
Gut - 10 Dec 2024
Makino Yuki, Rajapakshe Kimal I, Chellakkan Selvanesan Benson, Okumura Takashi, Date Kenjiro, Dutta Prasanta, Abou-Elkacem Lotfi, Sagara Akiko, Min Jimin, Sans Marta, Yee Nathaniel, Siemann Megan J, Enriquez Jose, Smith Paytience, Bhattacharya Pratip, Kim Michael, Dede Merve, Hart Traver, Maitra Anirban, Thege Fredrik Ivar
Abstract excerpt
BACKGROUND: Oncogenic 'hotspot' mutations of KRAS and GNAS are two major driver alterations in intraductal papillary mucinous neoplasms (IPMNs), which are bona fide precursors to pancreatic ductal adenocarcinoma. We previously reported that pancreas-specific Kras G12D and Gnas R201C co-expression in p48Cre; KrasLSL-G12D; Rosa26LSL-rtTA; Tg (TetO-GnasR201C) mice ('Kras;Gnas' mice) caused development of cystic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
